• Hlavní
  • Analytika
  • Zprávy z trhu
  • Company news: AstraZeneca (AZN) quarterly earnings miss analysts’ expectations
Ekonomické zprávy
12.11.2021

Company news: AstraZeneca (AZN) quarterly earnings miss analysts’ expectations

AstraZeneca (AZN) reported Q3 FY 2021 earnings of $1.08 per share (versus $0.94 per share in Q3 FY 2020), missing analysts’ consensus estimate of $1.25 per share.

The company’s quarterly revenues amounted to $9.741 bln (+48.1% y/y), beating analysts’ consensus estimate of $9.580 bln.

The company also reaffirmed guidance for FY 2021, projecting EPS of $5.05-5.40 versus analysts’ consensus estimate of $5.27.

AZN fell to $60.92 (-3.18%) in pre-market trading.

Podívejte se také